{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:07:13Z","timestamp":1784786833175,"version":"3.55.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High-risk human papillomavirus (HR-HPV) infection is the primary driver of cervical cancer. Emerging evidence indicates that the tumor microenvironment (TME) undergoes severe metabolic rewiring, which may accelerate T cell exhaustion (TEX) and impair immune checkpoint blockade (ICB). However, the molecular mechanisms coupling HPV-driven metabolism to T cell dysfunction remain incompletely elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This review summarizes immunometabolic interactions in the cervical cancer TME. We examined the metabolic alterations induced by HPV oncoproteins (E6\/E7) and how they reshape nutrient availability, lactate accumulation, and lipid peroxidation to drive anti-tumor CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell exhaustion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HPV-driven aerobic glycolysis and IDO1-mediated tryptophan catabolism establish severe metabolic barriers, causing nutrient deprivation and histone lactylation in infiltrating lymphocytes. These alterations are associated with persistent mitochondrial stress and ferroptosis, accelerating terminal TEX. In preclinical models, natural products (e.g., curcumin, berberine, quercetin, and artemisinin derivatives) can counteract this immunosuppressive rewiring by targeting checkpoints such as HIF-1\u03b1, PKM2, and AMPK; however, direct evidence of CD8\n                      <jats:sup>+<\/jats:sup>\n                      tumor-infiltrating lymphocyte rescue in HPV-specific immune-competent systems remains limited, largely inferred from other tumor types. Nanomedicine delivery may further enhance the bioavailability and targeting of these herbal components.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HPV-induced metabolic reprogramming is proposed to act as a fundamental checkpoint driving T cell exhaustion in cervical cancer. Targeting these immunometabolic barriers using natural compounds, particularly via nanomedicine-based delivery strategies, represents a promising but still largely preclinical avenue to synergize with conventional immunotherapies and potentially overcome resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1892919","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:41:15Z","timestamp":1784785275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products"],"prefix":"10.3389","volume":"17","author":[{"given":"Liang","family":"Wei","sequence":"first","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]},{"name":"National Clinical Research Center for Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou","family":"Menghui","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]},{"name":"National Clinical Research Center for Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Dandan","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]},{"name":"National Clinical Research Center for Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Xin","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]},{"name":"National Clinical Research Center for Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Xinying","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]},{"name":"National Clinical Research Center for Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Guangyi","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]},{"name":"National Clinical Research Center for Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Jing","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","place":["Tianjin, China"]},{"name":"National Clinical Research Center for Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01224-z","article-title":"Epigenetic regulation of T cell exhaustion","volume":"23","author":"Belk","year":"2022","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.67770","article-title":"HPV E6\/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression","volume":"18","author":"Hu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0384","article-title":"Pharmacological screening identifies metabolic vulnerabilities of CD8+ T cells","volume":"9","author":"Drijvers","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12182","article-title":"Metabolic regulation in the immune response to cancer","volume":"41","author":"Wu","year":"2021","journal-title":"Cancer Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12986-021-00615-7","article-title":"Metabolic reprogramming in cervical cancer and metabolomics perspectives","volume":"18","author":"Li","year":"2021","journal-title":"Nutr Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.07.012","article-title":"Carbon source availability drives nutrient utilization in CD8+ T cells","volume":"34","author":"Kaymak","year":"2022","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.01.040","article-title":"Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions","volume":"22","author":"Menk","year":"2018","journal-title":"Cell Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1186\/s12967-025-07272-x","article-title":"Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy","volume":"23","author":"Dong","year":"2025","journal-title":"J Transl Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01985-9","article-title":"Histone lactylation drives CD8+ T cell metabolism and function","volume":"25","author":"Raychaudhuri","year":"2024","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217835","article-title":"Lactylation in tumor microenvironment and immunotherapy resistance: new mechanisms and challenges","volume":"627","author":"Zhu","year":"2025","journal-title":"Cancer Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.06.001","article-title":"Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence","volume":"40","author":"Belk","year":"2022","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.807271","article-title":"Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives","volume":"13","author":"Peyraud","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70703","article-title":"The kynurenine pathway and indole pathway in tryptophan metabolism influence tumor progression","volume":"14","author":"Lu","year":"2025","journal-title":"Cancer Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217913","article-title":"Hypoxia and immunometabolism in the tumor microenvironment: insights into mechanisms and therapeutic potential","volume":"631","author":"Wu","year":"2025","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160025","article-title":"mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection","volume":"133","author":"Ando","year":"2023","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3441","article-title":"BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers","volume":"17","author":"Roychoudhuri","year":"2016","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0793-3","article-title":"Disturbed mitochondrial dynamics in CD8 TILs reinforce T cell exhaustion","volume":"21","author":"Yu","year":"2020","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.08.012","article-title":"Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency","volume":"155","author":"Cogliati","year":"2013","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0725-2","article-title":"Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen","volume":"21","author":"Vardhana","year":"2020","journal-title":"Nat Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8 T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8 T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1255443","article-title":"The crosstalk of CD8+ T cells and ferroptosis in cancer","volume":"14","author":"Lin","year":"2024","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2767","article-title":"Ginsenoside 20(S)Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells","volume":"46","author":"Li","year":"2015","journal-title":"Int J Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179418","article-title":"Anti-Warburg mechanism of ginsenoside F2 in human cervical cancer cells via activation of miR-193a-5p and inhibition of \u03b2-catenin\/c-Myc\/hexokinase 2 signaling axis","volume":"25","author":"Shin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"14517","DOI":"10.1038\/s41598-018-31615-y","article-title":"Shikonin inhibits tumor growth in mice by suppressing pyruvate kinase M2-mediated aerobic glycolysis","volume":"8","author":"Zhao","year":"2018","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15057974","article-title":"Human papillomavirus 16 E6 contributes HIF-1\u03b1 induced Warburg effect by attenuating the VHL-HIF-1\u03b1 interaction","volume":"15","author":"Guo","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.1038\/s41598-018-25524-3","article-title":"Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF-1\u03b1 inhibition","volume":"8","author":"Siddiqui","year":"2018","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/nu18010053","article-title":"Curcumin rewires the tumor metabolic landscape: mechanisms and clinical prospects","volume":"18","author":"Sun","year":"2025","journal-title":"Nutrients"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/171122","article-title":"The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer","volume":"19","author":"Zahedi","year":"2023","journal-title":"Arch Med Sci."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.07.027","article-title":"Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction","volume":"208","author":"Jia","year":"2018","journal-title":"Life Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/bab.2060","article-title":"Phytocompounds curcumin, quercetin, indole-3-carbinol, and resveratrol modulate lactate-pyruvate level along with cytotoxic activity in HeLa cervical cancer cells","volume":"68","author":"Pani","year":"2021","journal-title":"Biotechnol Appl Biochem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10637-018-0644-3","article-title":"The monocarboxylate transporter inhibitor quercetin induces intracellular acidification in a mouse model of glioblastoma multiforme","volume":"37","author":"Albatany","year":"2019","journal-title":"Invest New Drugs"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.019","article-title":"Lactate metabolism in human lung tumors","volume":"171","author":"Faubert","year":"2017","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8+ T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-39","article-title":"Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells","volume":"10","author":"Mahata","year":"2011","journal-title":"Mol Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040478","article-title":"Regulation of cell signaling pathways by berberine in different cancers","volume":"11","author":"Farooqi","year":"2019","journal-title":"Cancers"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112351","article-title":"Berberine activates AMPK and promotes mitochondrial biogenesis to attenuate oxidative stress in osteoblasts","volume":"144","author":"Pereira","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6318","article-title":"Berberine decelerates glucose metabolism via suppression of mTOR-dependent HIF-1\u03b1 protein synthesis in colon cancer cells","volume":"39","author":"Mao","year":"2018","journal-title":"Oncol Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3892\/or.2021.8204","article-title":"Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt\/mTOR\/GLUT1 signaling pathway","volume":"46","author":"Guo","year":"2021","journal-title":"Oncol Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.08.035","article-title":"Mitochondrial dynamics controls T cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2714","article-title":"Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen","volume":"14","author":"Doedens","year":"2013","journal-title":"Nat Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075139","article-title":"Resveratrol inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1","volume":"8","author":"Zou","year":"2013","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13081004","article-title":"Sodium selenite induces autophagy and apoptosis in cervical cancer cells via mitochondrial ROS-activated AMPK\/mTOR\/FOXO3a pathway","volume":"13","author":"Lv","year":"2024","journal-title":"Antioxidants"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121723","article-title":"Regulatory effect of Ficus carica latex on cell cycle progression in human papillomavirus-positive cervical cancer cell lines","volume":"16","author":"Cakir","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713646","article-title":"Ficus carica latex modulates immunity-linked gene expression in human papillomavirus-positive cervical cancer cell lines","volume":"24","author":"Cakir","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1021\/jf903377e","article-title":"Indoleamine 2,3-dioxygenase is suppressed by (-)-epigallocatechin-3-gallate via blocking of $\u03b3$-interferon-induced JAK-PKC-$\u03b4$-STAT1 signaling in human oral cancer cells","volume":"58","author":"Cheng","year":"2010","journal-title":"J Agric Food Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.03.052","article-title":"Identification of baicalein as a ferroptosis inhibitor by natural product library screening","volume":"473","author":"Xie","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153707","article-title":"Artematrolide A inhibited cervical cancer cell proliferation via ROS\/ERK\/mTOR pathway and metabolic shift","volume":"91","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1156062","article-title":"Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis","volume":"10","author":"Shi","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1657905","article-title":"Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic implications","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.3390\/molecules30153177","article-title":"Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications","volume":"30","author":"Parvin","year":"2025","journal-title":"Molecules"},{"key":"B77","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201600124","article-title":"Reactive-oxygen-species-responsive drug delivery systems: promises and challenges","volume":"4","author":"Saravanakumar","year":"2017","journal-title":"Adv Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/sstr.202000018","article-title":"Drug targeting via platelet membrane-coated nanoparticles","volume":"1","author":"Wang","year":"2020","journal-title":"Small Struct"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120711","article-title":"Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA\/Resveratrol with dual-responsive polyplexes","volume":"271","author":"Jia","year":"2021","journal-title":"Biomaterials"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3504","article-title":"Targeting cancer metabolism: a therapeutic window opens","volume":"10","author":"Vander Heiden","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.12.034","article-title":"Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia","volume":"132","author":"Garcia","year":"2014","journal-title":"Gynecol Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30409-1","article-title":"Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1892919\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:41:17Z","timestamp":1784785277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1892919\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":87,"alternative-id":["10.3389\/fimmu.2026.1892919"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1892919","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1892919"}}